HYMATIL 300 MG/ML SOLUTION FOR INJECTION FOR CATTLE AND SHEEP

Země: Irsko

Jazyk: angličtina

Zdroj: HPRA (Health Products Regulatory Authority)

Koupit nyní

Aktivní složka:

TILMICOSIN

Dostupné s:

Industrial Veterinaria, S.A.

ATC kód:

QJ01FA91

INN (Mezinárodní Name):

TILMICOSIN

Dávkování:

300 Mg/Ml

Léková forma:

Solution for Injection

Druh předpisu:

VPO-Vet.Practitioner Only

Terapeutické skupiny:

Bovine, Ovine

Terapeutické oblasti:

Tilmicosin

Terapeutické indikace:

Antibacterial

Stav Autorizace:

Authorised

Datum autorizace:

2010-12-17

Charakteristika produktu

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Hymatil 300 mg/ml solution for injection for cattle and sheep.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Tilmicosin..............................................................
300
mg
EXCIPIENTS:
Propylene glycol....................................................
250
mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection.
Clear, yellowish to brown-yellowish solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle and sheep.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Cattle:
Treatment of bovine respiratory disease associated with_ Mannheimia
haemolytica_ and_ Pasteurella multocida._
Treatment of interdigital necrobacillosis.
Sheep:
Treatment of respiratory tract infections caused by_ Mannheimia
haemolytica_ and_ Pasteurella multocida_.
Treatment of foot rot in sheep caused by_ Dichelobacter nodosus_ and_
Fusobacterium necrophorum_.
Treatment of acute ovine mastitis caused by_ Staphylococcus aureus_
and_ Mycoplasma agalactiae_.
4.3 CONTRAINDICATIONS
Do not administer intravenously.
Do not administer intramuscularly.
Do not administer to lambs weighing less than 15 kg.
Do not administer to primates.
Do not administer to pigs.
Do not administer to horses and donkeys.
Do not administer to goats.
Do not use in case of hypersensitivity to the active substance or to
any of the excipients.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n
                                
                                Přečtěte si celý dokument
                                
                            

Vyhledávejte upozornění související s tímto produktem